Svein I. Helle
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Reply to M. Kamrava and F. Montorsi et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 17, 2024
Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 23, 2024
Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort study.
Journal: Frontiers in oncology
Published: December 12, 2022
A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: March 12, 2022
Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer.
Journal: Advances in radiation oncology
Published: November 05, 2019
Impact of positive surgical margins on secondary treatment, palliative radiotherapy and prostate cancer-specific mortality. A population-based study of 13 198 patients.
Journal: The Prostate
Published: August 02, 2019
Statistical motion modelling for robust evaluation of clinically delivered accumulated dose distributions after curative radiotherapy of locally advanced prostate cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: August 07, 2017
An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 29, 2017
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.
Journal: European urology
Published: February 16, 2017
Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
Journal: Psychological medicine
Published: August 19, 2016
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial.
Journal: The Lancet. Oncology
Published: December 03, 2014
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
Journal: The Lancet. Oncology
Published: May 20, 2014
Last Updated: 09/26/2026